Last reviewed · How we verify
NCT06816849: H20KIDS
Hydration in Children and Adolescents With Primary Headaches
NA trial testing Recommended water intake in Primary Headaches (Includes Migraines, Tension, Cluster Headaches) in 60 participants. Completed in 30 June 2024.
31 October 2023
Quick facts
| Lead sponsor | University Medical Centre Ljubljana |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 March 2023 |
| Primary completion | 31 October 2023 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Slovenia |
Drugs / interventions tested
- Recommended water intake
Conditions studied
- Primary Headaches (Includes Migraines, Tension, Cluster Headaches) — all drugs for Primary Headaches (Includes Migraines, Tension, Cluster Headaches) →
- Hydration — all drugs for Hydration →
- Adolescent — all drugs for Adolescent →
- Children — all drugs for Children →
Sponsor
University Medical Centre Ljubljana
Who can join
Adults 4 to 18, any sex, with Primary Headaches (Includes Migraines, Tension, Cluster Headaches) or Hydration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the role of hydration and fluid intake in children and adolescents with primary headaches.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06816849
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Medical Centre Ljubljana trials
Trials by the same sponsor.
- NCT07466472 — Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity · not yet recruiting
- NCT07446244 — Catheter Ablation of Advanced Forms of Atrial Fibrillation · NA · enrolling by invitation
- NCT07109076 — Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton · NA · recruiting
- NCT07354880 — Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease · Phase 4 · not yet recruiting
- NCT07496736 — Post-exposure Influenza Prophylaxis in a Hospital Setting · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06816849 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Ljubljana
- Last refreshed: 10 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06816849.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing